207 related articles for article (PubMed ID: 8922190)
1. Carcinomatous meningitis in solid tumours.
Jayson GC; Howell A
Ann Oncol; 1996 Oct; 7(8):773-86. PubMed ID: 8922190
[TBL] [Abstract][Full Text] [Related]
2. Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant.
Jayson GC; Howell A; Harris M; Morgenstern G; Chang J; Ryder WD
Cancer; 1994 Dec; 74(12):3135-41. PubMed ID: 7982179
[TBL] [Abstract][Full Text] [Related]
3. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.
Ferreira Filho AF; Cardoso F; Di Leo A; Awada A; da Silva VD; Tovar RB; Schwartsmann G
Ann Oncol; 2001 Dec; 12(12):1757-9. PubMed ID: 11843255
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
5. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.
Chamberlain MC
Neurology; 1998 Apr; 50(4):1173-5. PubMed ID: 9566421
[TBL] [Abstract][Full Text] [Related]
6. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Grossman SA; Finkelstein DM; Ruckdeschel JC; Trump DL; Moynihan T; Ettinger DS
J Clin Oncol; 1993 Mar; 11(3):561-9. PubMed ID: 8445432
[TBL] [Abstract][Full Text] [Related]
7. [Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].
Kubo M; Jida M; Yamane M; Miyatani K; Udaka T; Sogabe O; Maeda H; Mizuta M; Shirakawa K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2097-9. PubMed ID: 16352935
[TBL] [Abstract][Full Text] [Related]
8. Carcinomatous meningitis and solid tumours.
Strady C; Ricciarelli A; Nasca S; Liautaud-Roger F; Coninx P
Oncol Rep; 2000; 7(1):203-7. PubMed ID: 10601619
[TBL] [Abstract][Full Text] [Related]
9. Carcinomatous Meningitis: it does not have to be a death sentence.
Sagar SM
Oncology (Williston Park); 2002 Feb; 16(2):237-43; discussion 244, 249-50. PubMed ID: 11866138
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
[TBL] [Abstract][Full Text] [Related]
11. Carcinomatous meningitis: clinical manifestations and management.
Zachariah B; Zachariah SB; Varghese R; Balducci L
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):7-12. PubMed ID: 7711996
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain Tumors.
Chowdhary S; Damlo S; Chamberlain MC
Cancer Control; 2017 Jan; 24(1):S1-S16. PubMed ID: 28557973
[TBL] [Abstract][Full Text] [Related]
16. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy.
Chamberlain MC; Kormanik PR
J Neurooncol; 1997 Oct; 35(1):55-64. PubMed ID: 9266441
[TBL] [Abstract][Full Text] [Related]
17. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.
Sakai M; Ishikawa S; Ito H; Ozawa Y; Yamamoto T; Onizuka M; Sakakibara Y
Int J Clin Oncol; 2006 Jun; 11(3):243-5. PubMed ID: 16850132
[TBL] [Abstract][Full Text] [Related]
18. Carcinomatous meningitis secondary to cholangiocarcinoma without other systemic metastasis.
Okamura Y; Harada A; Maeda A; Fujioka A; Horiba T; Ishigure K; Hirai A; Ito Y; Uesaka K
J Hepatobiliary Pancreat Surg; 2008; 15(2):237-9. PubMed ID: 18392723
[TBL] [Abstract][Full Text] [Related]
19. Postcontrast MRI of cranial meninges: leptomeningitis versus pachymeningitis.
Kioumehr F; Dadsetan MR; Feldman N; Mathison G; Moosavi H; Rooholamini SA; Verma RC
J Comput Assist Tomogr; 1995; 19(5):713-20. PubMed ID: 7560315
[TBL] [Abstract][Full Text] [Related]
20. Carcinomatous meningitis in a case of anaplastic meningioma.
Vinchon M; Ruchoux MM; Lejeune JP; Assaker R; Christiaens JL
J Neurooncol; 1995; 23(3):239-43. PubMed ID: 7673986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
